This activity is expired and is no longer available for CME credit.


Increased neutralization capacity of TNF-α in sera of MS patients may play a role in MS pathogenesis and is reversed by therapy with interferon-β

Author(s)/Faculty: Arnon Karni, MD, PhD
Release Date: 2/6/2015Expiration Date: 12/16/2019
Credit Type: CMENumber of Credits: 0
Content Type: VideoProvider:
Dr. Karni discusses the role of TNF-alpha in MS.